Guggenheim Partners has renewed its lease at 330 Madison Avenue for 17 years, and will expand from 240,000 square feet to 360,000 square feet. JLL, Guggenheim and MEAG, reinsurer Munich Re’s asset ...

It doesn’t take a six-figure supercar or a concours queen to make jaws drop. Sometimes all it takes is a dusty garage, a forgotten key, and the stubbornness of two gearheads who refuse to give up.

SEOUL (Reuters) -Celltrion Inc. said in a regulatory filing in South Korea on Tuesday its U.S. subsidiary has acquired Imclone Systems LLC from Eli Lilly in the United States for $330 million. In a ...

Big touchdown by a big man in a big game. The drama peaked in the final seconds. With just three ticks left, Rams kicker Joshua Karty lined up for a 44-yard attempt to tie the game. Instead, the kick ...

Soluna Holdings (NASDAQ: SLNH) stock has leapt roughly 116% over the past week and 330% over the last month, driven by renewed investor interest in its green data center model and recent financing ...

General Dynamics Corporation stock has reached an all-time high, hitting a price of 330.39 USD, capping an impressive year-to-date return of 25.11%. With a market capitalization of $88.48 billion, the ...

The prime minister is set to announce a ‘pride in place’ programme later today with funding for 330 places described as “overlooked communities”. Today’s announcement from Sir Keir Starmer is expected ...

Episode 34 of the ongoing Halemaumau eruption wrapped up abruptly just after 7 a.m. today, only six hours after fountains first roared to life inside Kilauea’s summit crater. The U.S. Geological ...

Sir Keir Starmer is to announce a "Pride in Place" programme with funding for over 330 disadvantaged communities as part of a fightback against Reform UK. The money will come alongside new powers for ...

Oregon Gov. Tina Kotek held media availability Monday to answer questions about the passage of the state’s transportation funding plan. Reporters also asked questions about the planned federal troop ...

Our team of savvy editors independently handpicks all recommendations. If you make a purchase through our links, we may earn a commission. Deals and coupons were accurate at the time of publication ...

After teasing its position in a bidding contest for a large-scale drug substance plant in the U.S. this summer, South Korea’s Celltrion has sealed the deal. Celltrion—which specializes in biosimilar ...